GT199100031A - Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas. - Google Patents
Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas.Info
- Publication number
- GT199100031A GT199100031A GT199100031A GT199100031A GT199100031A GT 199100031 A GT199100031 A GT 199100031A GT 199100031 A GT199100031 A GT 199100031A GT 199100031 A GT199100031 A GT 199100031A GT 199100031 A GT199100031 A GT 199100031A
- Authority
- GT
- Guatemala
- Prior art keywords
- asthma
- arthritis
- treatment
- azabencimidazoles
- related diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
ESTA INVENCION COMPRENDE COMPUESTOS DE ESTRUCTURA QUIMICA CONTENIDA EN LA FICHA TECNICA RESPECTIVA. ESTOS COMPUESTOS SON INHIBIDORES DEL FACTOR ACTIVAENTE DE PLAQUETAS (PAF) Y DE LOS SITIOS DE UNION DEL RECEPTOR LTD4, SON UTILES EN EL TRATAMIENTO O PREVENICION DEL ASMA, ARTRITIS, PSORIASIS Y UNA VARIEDAD DE TRASTORNOS INFLAMATORIOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52119990A | 1990-05-09 | 1990-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT199100031A true GT199100031A (es) | 1992-10-30 |
Family
ID=24075786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT199100031A GT199100031A (es) | 1990-05-09 | 1991-05-09 | Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas. |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0533695B1 (es) |
| JP (1) | JPH0678340B2 (es) |
| CN (1) | CN1057839A (es) |
| AP (1) | AP224A (es) |
| AT (1) | ATE112567T1 (es) |
| AU (1) | AU642265B2 (es) |
| BR (1) | BR9106433A (es) |
| CA (1) | CA2080476A1 (es) |
| DE (1) | DE69104481T2 (es) |
| DK (1) | DK0533695T3 (es) |
| ES (1) | ES2061247T3 (es) |
| FI (1) | FI925053A0 (es) |
| GT (1) | GT199100031A (es) |
| HU (1) | HUT62894A (es) |
| IE (1) | IE911553A1 (es) |
| IL (1) | IL98075A0 (es) |
| MA (1) | MA22151A1 (es) |
| MY (1) | MY105512A (es) |
| NO (1) | NO924290L (es) |
| NZ (1) | NZ238089A (es) |
| PE (1) | PE26691A1 (es) |
| PT (1) | PT97616A (es) |
| RO (1) | RO109450B1 (es) |
| TW (1) | TW205549B (es) |
| WO (1) | WO1991017163A1 (es) |
| YU (1) | YU81191A (es) |
| ZA (1) | ZA913497B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9102997D0 (en) * | 1991-02-13 | 1991-03-27 | Pfizer Ltd | Therapeutic agents |
| WO1994004537A2 (en) * | 1992-08-20 | 1994-03-03 | Cytomed, Inc. | Dual functional anti-inflammatory and immunosuppressive agents |
| US6372770B1 (en) | 1994-10-12 | 2002-04-16 | Euro-Celtique, S.A. | Benzoxazoles |
| US6232322B1 (en) | 1998-05-12 | 2001-05-15 | American Home Products Corporation | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| CA2330557A1 (en) * | 1998-05-12 | 1999-11-18 | Robert Emmett Mcdevitt | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6310081B1 (en) | 1999-05-10 | 2001-10-30 | American Home Products Corporation | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| EP3044210A4 (en) * | 2013-09-13 | 2017-03-15 | Cortendo AB (publ) | Novel cytochrome p450 inhibitors and their method of use |
| CN105348182B (zh) * | 2014-08-24 | 2018-04-13 | 复旦大学 | 2‑烷氧基苯甲酰芳胺类化合物及其药物用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES517193A0 (es) * | 1981-11-10 | 1983-12-01 | Wellcome Found | Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina. |
| GB8804439D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Dihydropyridines |
| GB8822170D0 (en) * | 1988-09-21 | 1988-10-26 | Pfizer Ltd | Therapeutic agents |
-
1991
- 1991-05-01 DE DE69104481T patent/DE69104481T2/de not_active Expired - Fee Related
- 1991-05-01 DK DK91909431.8T patent/DK0533695T3/da active
- 1991-05-01 BR BR919106433A patent/BR9106433A/pt not_active Application Discontinuation
- 1991-05-01 HU HU923496A patent/HUT62894A/hu unknown
- 1991-05-01 AU AU78671/91A patent/AU642265B2/en not_active Ceased
- 1991-05-01 WO PCT/US1991/002997 patent/WO1991017163A1/en active IP Right Grant
- 1991-05-01 JP JP3509156A patent/JPH0678340B2/ja not_active Expired - Fee Related
- 1991-05-01 ES ES91909431T patent/ES2061247T3/es not_active Expired - Lifetime
- 1991-05-01 RO RO92-01395A patent/RO109450B1/ro unknown
- 1991-05-01 CA CA002080476A patent/CA2080476A1/en not_active Abandoned
- 1991-05-01 EP EP91909431A patent/EP0533695B1/en not_active Expired - Lifetime
- 1991-05-01 AT AT91909431T patent/ATE112567T1/de not_active IP Right Cessation
- 1991-05-07 IL IL98075A patent/IL98075A0/xx unknown
- 1991-05-08 IE IE155391A patent/IE911553A1/en unknown
- 1991-05-08 MA MA22421A patent/MA22151A1/fr unknown
- 1991-05-08 TW TW080103606A patent/TW205549B/zh active
- 1991-05-08 ZA ZA913497A patent/ZA913497B/xx unknown
- 1991-05-08 NZ NZ238089A patent/NZ238089A/en unknown
- 1991-05-08 CN CN91103959A patent/CN1057839A/zh active Pending
- 1991-05-08 PE PE1991185432A patent/PE26691A1/es unknown
- 1991-05-08 MY MYPI91000776A patent/MY105512A/en unknown
- 1991-05-08 AP APAP/P/1991/000259A patent/AP224A/en active
- 1991-05-09 PT PT97616A patent/PT97616A/pt not_active Application Discontinuation
- 1991-05-09 GT GT199100031A patent/GT199100031A/es unknown
- 1991-05-09 YU YU81191A patent/YU81191A/sh unknown
-
1992
- 1992-11-06 NO NO92924290A patent/NO924290L/no unknown
- 1992-11-06 FI FI925053A patent/FI925053A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MY105512A (en) | 1994-10-31 |
| AU642265B2 (en) | 1993-10-14 |
| CN1057839A (zh) | 1992-01-15 |
| ATE112567T1 (de) | 1994-10-15 |
| TW205549B (es) | 1993-05-11 |
| AU7867191A (en) | 1991-11-27 |
| PT97616A (pt) | 1992-03-31 |
| IL98075A0 (en) | 1992-06-21 |
| RO109450B1 (ro) | 1995-02-28 |
| ES2061247T3 (es) | 1994-12-01 |
| DE69104481D1 (de) | 1994-11-10 |
| FI925053A (fi) | 1992-11-06 |
| EP0533695A1 (en) | 1993-03-31 |
| HUT62894A (en) | 1993-06-28 |
| DE69104481T2 (de) | 1995-02-09 |
| FI925053A0 (fi) | 1992-11-06 |
| WO1991017163A1 (en) | 1991-11-14 |
| IE911553A1 (en) | 1991-11-20 |
| BR9106433A (pt) | 1993-05-04 |
| CA2080476A1 (en) | 1991-11-10 |
| YU81191A (sh) | 1994-06-10 |
| ZA913497B (en) | 1992-12-30 |
| AP224A (en) | 1992-10-27 |
| JPH0678340B2 (ja) | 1994-10-05 |
| JPH05505619A (ja) | 1993-08-19 |
| DK0533695T3 (da) | 1995-01-09 |
| EP0533695B1 (en) | 1994-10-05 |
| MA22151A1 (fr) | 1991-12-31 |
| NO924290D0 (no) | 1992-11-06 |
| HU9203496D0 (en) | 1993-01-28 |
| PE26691A1 (es) | 1991-10-21 |
| NO924290L (no) | 1992-11-06 |
| NZ238089A (en) | 1992-10-28 |
| AP9100259A0 (en) | 1991-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27258A1 (es) | Derivados de dihidro-benzo b 1, 4 diazepin-2-ona como antagonistas ii mglur2 | |
| DK0693073T3 (da) | Bicykliske ansamyciner og deres anvendelse som antitumormidler | |
| GT199100031A (es) | Azabencimidazoles en el tratamiento de asma, artritis y en- fermedades relacionadas. | |
| GT199700089A (es) | Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido. | |
| ES2162061T3 (es) | Derivados de piperidina como antagonistas de la neuroquinina. | |
| PA8524101A1 (es) | 2-(4-PIRIDIL) AMINO-6-DIALCOXIFENIL-PIRIDO [2,3-d] PIRIMIDIN-7-ONAS | |
| ECSP034796A (es) | DERIVADOS DIHIDRO-BENZO[b][1,4]DIAZEPIN-2-ONA ANTAGONISTAS I MGLUR2 | |
| GT199900146A (es) | Derivados de 4,4-biarilpiperidina. | |
| DK0577394T3 (da) | Morpholin- og thiomorpholin-tachykininreceptorantagonister | |
| ATE278673T1 (de) | Disubstituierte pyrazoline und triazoline als faktor xa inhibitoren | |
| ES2058306T3 (es) | Tetralinas substituidas, cromanos y compuestos relacionados en el tratamiento del asma, artritis y enfermedades relacionadas. | |
| DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
| SE9802729D0 (sv) | Novel Compounds | |
| GT199800205A (es) | Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgesicos. | |
| CY1105482T1 (el) | Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων | |
| DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
| TR200000005T2 (tr) | Sıtmaya karşı ß-alkoksiakrilatlar. | |
| MX9300409A (es) | Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas. | |
| ES2156889T3 (es) | Compuestos biciclicos antagonistas de receptores de aminoacidos excitativos. | |
| UY27394A1 (es) | Pedidos con actividad anti- angiogéna. | |
| UY26498A1 (es) | Pirroles sustituidos | |
| SE0001631D0 (sv) | New use | |
| ITRM920441A1 (it) | Composizioni monomere per il rivestimento del calcestruzzo. | |
| UY26207A1 (es) | Antagonistas de los receptores de la il-8. | |
| ES2077358T3 (es) | N-alquil-3-fenil-3-(2-alquiltiofenoxi)propilaminas. |